Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:DNATSE:ITHNYSE:NVONASDAQ:TLRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDNAGinkgo Bioworks$6.99+2.0%$7.21$5.00▼$27.16$409.14M1.291.46 million shs1.03 million shsITHInternational Tower Hill MinesC$1.20+1.7%C$0.94C$0.57▼C$1.33C$168.48M1.1736,015 shs23,942 shsNVONovo Nordisk A/S$67.26-1.3%$66.31$57.00▼$148.15$302.24B0.656.70 million shs6.50 million shsTLRYTilray$0.44-1.0%$0.52$0.41▼$2.15$445.27M1.9528.29 million shs14.62 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDNAGinkgo Bioworks0.00%-11.76%-11.41%-35.61%-80.39%ITHInternational Tower Hill Mines0.00%+30.43%+30.43%+69.01%+26.32%NVONovo Nordisk A/S0.00%+4.53%+7.46%-23.62%-49.84%TLRYTilray0.00%-10.63%-10.14%-53.50%-76.22%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationDNAGinkgo Bioworks1.0834 of 5 stars0.83.00.00.02.72.51.3ITHInternational Tower Hill MinesN/AN/AN/AN/AN/AN/AN/AN/ANVONovo Nordisk A/S4.6787 of 5 stars4.23.02.50.03.20.04.4TLRYTilray1.3731 of 5 stars3.11.00.00.01.90.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDNAGinkgo Bioworks 1.67Reduce$5.77-17.50% DownsideITHInternational Tower Hill Mines 0.00N/AN/AN/ANVONovo Nordisk A/S 2.38Hold$135.00100.71% UpsideTLRYTilray 2.25Hold$1.92333.24% UpsideCurrent Analyst Ratings BreakdownLatest ITH, NVO, DNA, and TLRY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/28/2025NVONovo Nordisk A/SHsbc Global ResSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy4/25/2025NVONovo Nordisk A/SDbs BankSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeSell4/17/2025NVONovo Nordisk A/SGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/17/2025NVONovo Nordisk A/SBMO Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform$105.00 ➝ $64.004/15/2025NVONovo Nordisk A/SBNP ParibasSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageStrong-Buy ➝ Underperform4/14/2025TLRYTilrayRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral4/9/2025TLRYTilrayPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$2.00 ➝ $1.003/13/2025NVONovo Nordisk A/SKepler Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy3/3/2025NVONovo Nordisk A/SStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDNAGinkgo Bioworks$237.42M1.72N/AN/A$21.93 per share0.32ITHInternational Tower Hill MinesN/AN/AC$0.05 per share22.50C$0.29 per shareN/ANVONovo Nordisk A/S$303.14B1.00$3.12 per share21.57$4.64 per share14.50TLRYTilray$210.48M2.12N/AN/A$4.14 per share0.11Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDNAGinkgo Bioworks-$892.87M-$9.16N/AN/AN/A-298.78%-58.54%-34.24%N/AITHInternational Tower Hill Mines-C$2.36M-C$0.02N/A∞N/AN/A-5.82%-3.65%N/ANVONovo Nordisk A/S$14.64B$3.3820.4414.430.9034.81%84.68%26.29%8/6/2025 (Estimated)TLRYTilray-$244.98M-$1.05N/AN/AN/A-30.95%-4.40%-3.57%8/4/2025 (Estimated)Latest ITH, NVO, DNA, and TLRY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025NVONovo Nordisk A/S$0.92$0.92N/A$0.92N/A$11.87 billion5/6/2025Q1 2025DNAGinkgo Bioworks-$1.23-$1.58-$0.35-$1.68$38.70 million$48.32 million4/8/2025Q3 2025TLRYTilray-$0.04-$0.10-$0.06-$0.87$213.38 million$185.78 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDNAGinkgo BioworksN/AN/AN/AN/AN/AITHInternational Tower Hill MinesN/AN/AN/AN/AN/ANVONovo Nordisk A/S$1.632.42%+25.26%48.22%N/ATLRYTilrayN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDNAGinkgo BioworksN/A5.795.79ITHInternational Tower Hill MinesN/A10.3730.48NVONovo Nordisk A/S0.620.740.55TLRYTilray0.102.541.58Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDNAGinkgo Bioworks78.63%ITHInternational Tower Hill Mines71.80%NVONovo Nordisk A/S11.54%TLRYTilray9.35%Insider OwnershipCompanyInsider OwnershipDNAGinkgo Bioworks9.72%ITHInternational Tower Hill Mines0.51%NVONovo Nordisk A/S0.07%TLRYTilray0.87%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDNAGinkgo Bioworks64058.53 million51.89 millionOptionableITHInternational Tower Hill Mines220140.40 millionN/ANot OptionableNVONovo Nordisk A/S54,4004.49 billion4.48 billionOptionableTLRYTilray2,6501.01 billion929.50 millionOptionableITH, NVO, DNA, and TLRY HeadlinesRecent News About These CompaniesTilray (NASDAQ:TLRY) Stock Price Down 2.2% - What's Next?May 24 at 4:02 PM | marketbeat.comTilray (NASDAQ:TLRY) Trading 1.6% Higher - Should You Buy?May 23 at 2:12 PM | marketbeat.comTilray (NASDAQ:TLRY) Trading Down 0.2% - Should You Sell?May 22 at 2:20 PM | marketbeat.comIntroducing Y'all's Beer: A True Taste of Texas from Revolver BrewingMay 22 at 8:00 AM | globenewswire.comTilray Medical Brings Canada's Iconic Cannabis Brand Good Supply to GermanyMay 22 at 7:00 AM | globenewswire.comTilray (NASDAQ:TLRY) Stock Price Up 1.5% - Still a Buy?May 21, 2025 | marketbeat.comTop Marijuana Stocks In A Volatile MarketMay 21, 2025 | marijuanastocks.comTilray (NASDAQ:TLRY) Shares Down 6.9% - Should You Sell?May 20, 2025 | marketbeat.comTidal Investments LLC Has $14.09 Million Position in Tilray Inc (NASDAQ:TLRY)May 20, 2025 | marketbeat.comTilray Brands (NasdaqGS:TLRY) Plans Reverse Stock SplitMay 17, 2025 | finance.yahoo.comTilray (NASDAQ:TLRY) Trading Up 4.5% - Time to Buy?May 17, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Shares Down 4.4% - Time to Sell?May 16, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Stock Price Down 1.4% - Here's What HappenedMay 15, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Stock Price Down 2.1% - Should You Sell?May 14, 2025 | marketbeat.comTilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and EdiblesMay 14, 2025 | globenewswire.comTilray Inc (NASDAQ:TLRY) Shares Purchased by Dimensional Fund Advisors LPMay 14, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Stock Price Up 1.2% - Here's WhyMay 13, 2025 | marketbeat.comBest Canadian Marijuana Stocks for U.S. Market ExposureMay 13, 2025 | marijuanastocks.com2 Stocks Near Their 52-Week Lows That Still Aren't Worth BuyingMay 13, 2025 | fool.comTilray (NASDAQ:TLRY) Shares Down 2.1% - Here's WhyMay 10, 2025 | marketbeat.comTilray (NASDAQ:TLRY) Trading Up 1.5% - Time to Buy?May 9, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesQualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongBy Sam Quirke | May 13, 2025View Qualcomm Is 5x Cheaper Than AMD, But Won’t Be for LongWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumBroadcom Set to Surge as AI Diffusion Rule EndsBy Leo Miller | May 15, 2025View Broadcom Set to Surge as AI Diffusion Rule EndsTop 5 Stocks Hedge Funds Are Buying Right NowBy Ryan Hasson | May 20, 2025View Top 5 Stocks Hedge Funds Are Buying Right NowD-Wave Pushes Back on Short Seller Case With Strong EarningsBy Nathan Reiff | May 14, 2025View D-Wave Pushes Back on Short Seller Case With Strong EarningsITH, NVO, DNA, and TLRY Company DescriptionsGinkgo Bioworks NYSE:DNA$6.99 +0.14 (+2.04%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$7.06 +0.07 (+0.99%) As of 05/23/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.International Tower Hill Mines TSE:ITHC$1.20 +0.02 (+1.69%) As of 05/23/2025 03:59 PM EasternInternational Tower Hill Mines Ltd. engages in the acquisition, exploration, and development of mineral properties. It holds rights to acquire interests in the Livengood gold project covering an area of approximately 19,546 hectares located to the northwest of Fairbanks, Alaska. The company was formerly known as Tower Hill Mines Ltd. and changed its name to International Tower Hill Mines Ltd. in March 1991. International Tower Hill Mines Ltd. was incorporated in 1978 and is headquartered in Vancouver, Canada.Novo Nordisk A/S NYSE:NVO$67.26 -0.91 (-1.33%) Closing price 05/23/2025 03:59 PM EasternExtended Trading$67.30 +0.04 (+0.06%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.Tilray NASDAQ:TLRY$0.44 0.00 (-1.03%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.44 0.00 (-0.09%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Alphabet Stock Lags—But Waymo May Be Its Hidden Driver This Market Sell-Off Might Trigger a Value Rotation Into Pepsi Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
